• Mc-Val-Cit-PABC-PNP: Technical Guidance for ADC Synthesis

  2026-07-17

  Mc-Val-Cit-PABC-PNP is a cathepsin B-cleavable ADC peptide linker designed for researchers developing antibody-drug conjugates requiring selective lysosomal payload release. Best suited for organic solvent-based workflows, it is not appropriate for aqueous, diagnostic, or clinical applications due to its solubility and intended use profile.

• EPZ5676: Potent DOT1L Inhibitor for MLL-Rearranged Leukemia

  2026-07-17

  EPZ5676 is a highly selective DOT1L inhibitor with nanomolar potency, enabling precise disruption of H3K79 methylation in MLL-rearranged leukemia models. Its exceptional selectivity and robust cytotoxicity in acute leukemia cell lines make it a cornerstone tool for histone methyltransferase inhibition assays. APExBIO provides EPZ5676 as a rigorously characterized research reagent.

• SCH772984: Redefining ERK1/2 Inhibition for Tumor Model Rese

  2026-07-16

  Explore the scientific foundations and experimental potential of SCH772984, a potent ERK1/2 inhibitor, in dissecting MAPK/ERK pathway inhibition and overcoming tumor radioresistance. This article delivers actionable insights for advanced cancer model design and translational research.

• SB 431542: Precision ALK5 Inhibition for Neuroinflammation R

  2026-07-16

  Explore the advanced use of SB 431542 as a potent ALK5 inhibitor for dissecting TGF-β signaling in neuroinflammation and Alzheimer’s research. This in-depth guide reveals unique scientific and experimental considerations, bridging molecular assay design with translational neuroscience.

• Vernakalant for Rapid Conversion of Atrial Fibrillation: Pha

  2026-07-15

  This phase 3, randomized, placebo-controlled trial demonstrates that vernakalant hydrochloride enables rapid and effective pharmacological conversion of recent-onset atrial fibrillation (AF) with a favorable safety profile. The findings highlight vernakalant's clinical potential as an alternative to electrical cardioversion and existing antiarrhythmic agents, streamlining acute AF management.

• Angiotensin II–HIF-1α Axis Regulates Ferroptosis and Radiore

  2026-07-15

  This study delineates how local angiotensin II (Ang II) suppresses ferroptosis and drives radioresistance in nasopharyngeal carcinoma (NPC) through the HIF-1α-HILPDA axis. The findings identify key molecular feedback loops and suggest that targeting both Ang II signaling and ferroptosis may enhance radiotherapy efficacy in NPC.

• Quaternization Enables Lung-Selective mRNA Delivery via Nano

  2026-07-14

  This study demonstrates that quaternization of lipid-like nanoassemblies transforms their organ tropism from spleen to lung, achieving over 95% mRNA expression in the lung after intravenous delivery. These findings offer a new chemical strategy for lung-targeted mRNA therapeutics, expanding the application scope of mRNA delivery systems beyond hepatic tissues.

• Irinotecan (CPT-11): Mechanistic Insight and Translational S

  2026-07-14

  This thought-leadership article explores Irinotecan (CPT-11) as a cornerstone of translational colorectal cancer research, weaving together its mechanistic underpinnings, experimental parameters, and emerging clinical challenges. It synthesizes new findings on DNA damage, tumor microenvironment modeling, and recent insights into chemotherapy-induced steatohepatitis, while providing strategic guidance for researchers seeking to maximize the translational impact of their Irinotecan-based studies.

• β-Elemene Suppresses Adipogenesis via AMPK Pathway in 3T3-L1

  2026-07-13

  This study demonstrates that β-Elemene inhibits adipogenesis in 3T3-L1 preadipocytes by activating the AMPK pathway, counteracting insulin resistance-induced lipid accumulation. The findings support β-Elemene's utility as a mechanistic probe in metabolic and obesity research workflows.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-07-13

  This study elucidates a pyroptosis-independent function for Gasdermin C (GSDMC) in pancreatic ductal adenocarcinoma (PDAC), showing that GSDMC enhances stemness and immune evasion by regulating gene expression from the nucleus. The findings reveal new molecular mechanisms and highlight GSDMC as a promising therapeutic target for overcoming resistance in aggressive PDAC.

• Ivermectin (SKU A2813): Reliable Solutions for Anti-Parasiti

  2026-07-12

  This scenario-driven guide demonstrates how Ivermectin (SKU A2813) meets the reproducibility, quality, and workflow challenges commonly encountered in anti-parasitic and cell viability research. Drawing on both product specifications and peer-reviewed findings, the article provides practical answers to real laboratory questions, positioning Ivermectin as a trusted anti-parasitic research compound for biomedical scientists.

• Isorhamnetin Promotes Oocyte Maturation via PI3K/Akt Activat

  2026-07-10

  The reference study demonstrates that isorhamnetin, a dietary flavonoid, promotes oocyte maturation by activating the PI3K/Akt pathway while reducing oxidative and endoplasmic reticulum stress. These findings provide mechanistic insight into improving in vitro oocyte quality and offer a foundation for potential infertility interventions.

• Ivermectin as a Broad-Spectrum Anti-Parasitic: Applied Workf

  2026-07-09

  Leverage Ivermectin's high-purity, broad-spectrum anti-parasitic properties to streamline parasitology drug development and advanced research. This guide delivers actionable workflow optimizations, troubleshooting tips, and integrates innovations from tumor biology to inspire next-generation assay design.

• Forskolin: Strategic Adenylate Cyclase Activation in Transla

  2026-07-09

  This thought-leadership article unpacks Forskolin’s mechanistic role as a direct adenylate cyclase activator, providing actionable guidance for translational researchers across stem cell, inflammation, and epithelial disease models. Integrating new mechanistic evidence and comparative findings, it positions APExBIO’s Forskolin as a strategic tool for bridging cellular insights to clinical translation.

• Proteinase K: Unraveling Enzymatic Precision in DNA Integrit

  2026-07-08

  Explore how Proteinase K, a broad-spectrum serine protease, enables uncompromising DNA integrity and contaminant removal across challenging molecular biology workflows. This article provides advanced insight into mechanistic action, optimal usage, and new findings in fungal vesicle research.

16822 records 1/1122 page Next 12345 下5页 Last page